PeptideScanner retained ClinicalTrials.gov record NCT00001259 at 2026-07-30T19:15:14.515Z. Its registry update date was 2023-03-02, and PeptideScanner's reviewed identity mapping was leuprolide. 1
This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. 1